Natalie R. van Zuydam
AstraZeneca (Sweden)(SE)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Birth, Development, and Health, Diabetes Treatment and Management, Pancreatic function and diabetes, Lipid metabolism and disorders
Most-Cited Works
- → Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases(2019)1,515 cited
- → An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans(2017)802 cited
- → Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors(2019)631 cited
- A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease(2015)
- → Genome-wide associations for birth weight and correlations with adult disease(2016)536 cited
- → Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies(2012)484 cited
- → Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease(2017)263 cited
- → Genome-wide characterization of circulating metabolic biomarkers(2024)221 cited
- → Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen(2019)211 cited
- → The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis(2013)203 cited